<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2092">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04793269</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00280</org_study_id>
    <nct_id>NCT04793269</nct_id>
  </id_info>
  <brief_title>Characteristics of Long COVID-19 Syndrome</brief_title>
  <official_title>Long COVID Syndrom: Charakterisierung Eines Neuen Krankheitsbildes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christian Clarenbach</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Characterization of patients with long COVID syndrome including symptoms, medical history and&#xD;
      persistent organ damage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Some people are very hesitant to recover from a COVID-19 infection and present persistent&#xD;
      symptoms. The participants still suffer after the acute phase of the infection from shortness&#xD;
      of breath, coughing, chest pain or fatigue. Therefore, a special interdisciplinary&#xD;
      consultation was built. The consulatation is not only addressed to people who have been&#xD;
      hospitalized due to COVID-19, but also to those with mild symptoms during infection. During&#xD;
      the consultation hours, personal health data are collected that serves as the basis for this&#xD;
      research project.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 23, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>once through study completion, an average of 6 months</time_frame>
    <description>modified medical research council (scale from 0 to 4)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>self-addressed Quality of life</measure>
    <time_frame>once through study completion, an average of 6 months</time_frame>
    <description>Short form health 36 questionnaire with 8 domains, each rated from 0-100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoracic pain</measure>
    <time_frame>once through study completion, an average of 6 months</time_frame>
    <description>assessed by medical interview (reported as yes or no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Medical history</measure>
    <time_frame>once through study completion, an average of 6 months</time_frame>
    <description>List of relevant morbidities assessed as present/not present by medical interview (e.g. respiratory, cardial, neurological, psychiatric diseases by interview and medical records)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fibrosis</measure>
    <time_frame>once through study completion, an average of 6 months</time_frame>
    <description>Assessed by chest CT, rated as present/not present</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial damage</measure>
    <time_frame>once through study completion, an average of 6 months</time_frame>
    <description>Assessed by myocardial damage, rated as present/not present</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Long COVID Syndrome</condition>
  <arm_group>
    <arm_group_label>Long COVID</arm_group_label>
    <description>Patients with long COVID syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>no intervention</description>
    <arm_group_label>Long COVID</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with long COVID syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Long COVID syndrome&#xD;
&#xD;
          -  age &gt;= 18 years&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Christian F Clarenbach, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Zurich, Pulmonology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian F Clarenbach, MD</last_name>
    <phone>+41 44 255 17 12</phone>
    <email>christian.clarenbach@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan Malesevic, MD</last_name>
    <phone>+41442551743</phone>
    <email>stefan.malesevic@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian F Clarenbach, MD</last_name>
      <phone>+49442551712</phone>
      <email>christian.clarenbach@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Stefan Malesevic, MD</last_name>
      <phone>+41442551743</phone>
      <email>stefan.malesevic@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 4, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2021</study_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Christian Clarenbach</investigator_full_name>
    <investigator_title>Sponsor Investigator</investigator_title>
  </responsible_party>
  <keyword>long COVID</keyword>
  <keyword>post COVID</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will be shared on request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

